The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Corcept Therapeutics
CORT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$35.60
0.73
2.09%
At Close: -
$35.60
0
0.00%
After Hours: Jul 26, 4:46 PM EDT
15 minutes delayed
Get Report
Comment
Q2 2024 earnings tomorrow on Mon Jul 29th after the market close
Conference call scheduled tomorrow at 17:00 PM
Click to view the webcast
Corcept Therapeutics (CORT) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Corcept Therapeutics (NASDAQ:CORT) Stock
Corcept Therapeutics Stock (NASDAQ: CORT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, July 11, 2024
Zevra Rises on Update on Niemann-Pick Disease Type C Drug
Zacks
Monday, July 01, 2024
Piper Sandler Reiterates Overweight on Corcep...
Benzinga Newsdesk
Monday, June 24, 2024
Corcept Therapeutics Announces Results From C...
Benzinga Newsdesk
Monday, June 17, 2024
6 Analysts Have This To Say About Corcept Therapeutics
Benzinga Insights
Truist Securities Maintains Buy on Corcept Th...
Benzinga Newsdesk
Friday, June 14, 2024
Concerpt Therapeutics Shares Are Trading Lower: What You Need To Know
Vaishali Prayag
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Corcept Therapeutics shares are trading lower...
Benzinga Newsdesk
Reported Late Thursday: Teva Sues Corcept Ove...
Benzinga Newsdesk
Friday, June 07, 2024
Witnessing An Insider Decision, Gary Charles Robb Exercises Options Valued At $443K At Corcept Therapeutics
Benzinga Insights
Tuesday, June 04, 2024
Corcept Therapeutics shares are trading highe...
Benzinga Newsdesk
Truist Securities Reiterates Buy on Corcept T...
Benzinga Newsdesk
Monday, June 03, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Corcept Therapeutics To Present Results Of Ph...
Benzinga Newsdesk
Wednesday, May 29, 2024
Corcept Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Corcept...
Benzinga Newsdesk
Tuesday, May 28, 2024
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Why Mid-Cap Corcept Therapeutics Stock Trading Higher On Tuesday?
Vandana Singh
Market-Moving News for May 28th
Benzinga Newsdesk
Corcept Therapeutics shares are trading highe...
Benzinga Newsdesk
Corcept Announces Phase 3 GRACE Trial Met Its...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Wednesday, May 22, 2024
LEONARD BAKER JR Makes A Tactical Move: Adds Corcept Therapeutics Stock Options To Portfolio
Benzinga Insights
Thursday, May 09, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Thursday, May 02, 2024
The Analyst Verdict: Corcept Therapeutics In The Eyes Of 4 Experts
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Corcept ...
Benzinga Newsdesk
Corcept Therapeutics shares are trading highe...
Benzinga Newsdesk
Truist Securities Maintains Buy on Corcept Th...
Benzinga Newsdesk
Wednesday, May 01, 2024
Corcept Therapeutics shares are trading highe...
Benzinga Newsdesk
Corcept Therapeutics Increases FY24 Revenue G...
Benzinga Newsdesk
Corcept Therapeutics Q1 EPS $0.25 Beats $0.22...
Benzinga Newsdesk
Monday, April 29, 2024
Corcept Completes Enrollment In Phase 4 CATAL...
Benzinga Newsdesk
Tuesday, April 23, 2024
HC Wainwright & Co. Reiterates Buy on Corcept...
Benzinga Newsdesk
Monday, April 22, 2024
Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter
Vandana Singh
Corcept Therapeutics Says Patients In The Ope...
Benzinga Newsdesk
Corcept Announces Results From Open-Label Por...
Benzinga Newsdesk
Monday, April 15, 2024
Corcept Completes Enrollment In Phase 2 DAZAL...
Benzinga Newsdesk
Monday, April 08, 2024
Corcept Completes Enrollment In Pivotal Phase...
Benzinga Newsdesk
Monday, April 01, 2024
Corcept Completes Enrollment In Phase 3 Gradi...
Benzinga Newsdesk
Friday, February 16, 2024
What's Going On With Stress Hormone Modulator-Focused Corcept Therapeutics' Stock Friday?
Vandana Singh
Thursday, February 15, 2024
Corcept Announces Preliminary Results From Pr...
Benzinga Newsdesk
Recap: Corcept Therapeutics Q4 Earnings
Benzinga Insights
Corcept Therapeutics Reiterated FY24 Revenue ...
Benzinga Newsdesk
Corcept Therapeutics Q4 2023 GAAP EPS $0.28 B...
Benzinga Newsdesk
Earnings Scheduled For February 15, 2024
Benzinga Insights
Wednesday, February 14, 2024
Earnings Preview: Corcept Therapeutics
Benzinga Insights
Significant Move: Gary Charles Robb Invests $105K In Corcept Therapeutics Stock Options
Benzinga Insights
A Noteworthy Decision By Atabak Mokari As Acquires $105K In Corcept Therapeutics Stock Options
Benzinga Insights
Hazel Hunt Sees Potential Growth And Acquires $105K In Corcept Therapeutics Stock Options
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch